glp 1 and anesthesia How should we approach patients on #GLP1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like A narrative review of glucagon-like

[1] [4] While this appetite suppression facilitates substantial weight loss, it also creates a clinical challenge: ensuring adequate protein intake to preserve lean body mass

Sulfur burps alone are not typically a reason to stop treatment

No Ozempic, Wegovy, Mounjaro, or Zepbound

Food and Drug Administration , 2025

The mechanism of action involves binding to GLP-1 receptors located throughout the body, including the pancreas, gastrointestinal tract, and importantly, the brain

Current data suggest that the oral formulation leads to clinically meaningful weight loss, but on average, it appears less effective than higher doses of high-efficacy injectable GLP-1 therapies, says Jaime Almandoz, MD, medical director of UT Southwestern Medical Centers weight wellness program